Showing results (811-820 of 857) with videos related to

Sort By:
Pageof 86
Translational Lung Cancer Research|March 24, 2017
Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysisPing Zhan, Qing-Qing Zhu, Ying-Ying Miu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical TrialMark A Exley, Phillip Friedlander, Nadia Alatrakchi, et al.
Brain Research|January 1, 2025
Repeated non-hemorrhagic and non-contusional mild traumatic brain injury in rats elicits behavioral impairment with microglial activation, astrogliosis, and tauopathy: Reproducible and quantitative model of chronic traumatic encephalopathyChiaki Sugahara, Kyohei Kin, Tatsuya Sasaki, et al.
The Journal of Medical Investigation : JMI|October 27, 2024
Comparison of endogenous hypothalamic and serum OT levels between young and middle-aged perimenopausal female ratsRie Masaki, Yuri Yamamoto, Kou Tamura, et al.
Breast Cancer Research and Treatment|September 9, 2023
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancerShinsuke Sasada, Naoto Kondo, Hiroya Hashimoto, et al.
Annals of Surgical Oncology|November 13, 2022
Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local RecurrencesAyu Yamaguchi, Makoto Ishitobi, Naomi Nagura, et al.
Endocrine Journal|February 28, 2024
Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine modelYuri Kadota, Takeshi Kato, Kana Kasai, et al.
Breast Cancer Research and Treatment|July 8, 2026
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALDNorikazu Masuda, Shigehira Saji, Yasuyuki Kojima, et al.
Cancer Biology & Therapy|October 12, 2010
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccinationMasanori Noguchi, Takashi Mine, Nobukazu Komatsu, et al.
Theranostics|June 7, 2021
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLCYayi He, Linsong Chen, Lishu Zhao, et al.
Pageof 86